Endo International Ordinary Shares reported $120.25M in EBIT for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Aerie Pharmaceuticals AERI:US $ -18137000 15.51M
Amarin AMRN:US -37619000 9.31M
Bristol Myers Squibb BMY:US $ 3197M 9M
Eli Lilly And LLY:US $ 1650.5M 919.4M
Hikma Pharmaceutical HIK:LN 256M 23M
Horizon Pharma HZNP:US 147M 49.44M
JAZZ PHA JAZZ:US 126.35M 38.8M
Lannett LCI:US $ -20301000 2.47M
Merk MRK:US $ 5711M 652M
Novartis NOVN:VX 3.32B 176M
Pacira Pharmaceuticals PCRX:US $ 13.18M 8.55M
Perrigo Ordinary Shares PRGO:US $ 2.6M 20.5M
Pfizer PFE:US $ 12099M 2104M
Phibro Animal Health PAHC:US $ 19.19M 3.1M
Revance Therapeutics RVNC:US $ -57842000 4.38M
Supernus Pharmaceuticals SUPN:US $ 11.35M 9.38M
Takeda 4502:JP 150.52B 152.13B
Teva Pharmaceutical TEVA:IT 734M 55M
Xeris Pharmaceuticals Inc XERS:US $ -18916000 158K
Zoetis ZTS:US $ 737M 57M